FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103876802> ?p ?o ?g. }

• W2103876802 endingPage "2753" @default.
• W2103876802 startingPage "2749" @default.
• W2103876802 abstract "The mycobacterium growth indicator tube (MGIT960) automated liquid medium testing method is becoming the international gold standard for second-line drug susceptibility testing of multidrug- and extensively drug-resistant Mycobacterium tuberculosis complex isolates. We performed a comparative study of the current gold standard in the Netherlands, the Middlebrook 7H10 agar dilution method, the MGIT960 system, and the GenoType MTBDRsl genotypic method for rapid screening of aminoglycoside and fluoroquinolone resistance. We selected 28 clinical multidrug- and extensively drug-resistant M. tuberculosis complex strains and M. tuberculosis H37Rv. We included amikacin, capreomycin, moxifloxacin, prothionamide, clofazimine, linezolid, and rifabutin in the phenotypic test panels. For prothionamide and moxifloxacin, the various proposed breakpoint concentrations were tested by using the MGIT960 method. The MGIT960 method yielded results 10 days faster than the agar dilution method. For amikacin, capreomycin, linezolid, and rifabutin, results obtained by all methods were fully concordant. Applying a breakpoint of 0.5 microg/ml for moxifloxacin led to results concordant with those of both the agar dilution method and the genotypic method. For prothionamide, concordance was noted only at the lowest and highest MICs. The phenotypic methods yielded largely identical results, except for those for prothionamide. Our study supports the following breakpoints for the MGIT960 method: 1 microg/ml for amikacin, linezolid, and clofazimine, 0.5 microg/ml for moxifloxacin and rifabutin, and 2.5 microg/ml for capreomycin. No breakpoint was previously proposed for clofazimine. For prothionamide, a division into susceptible, intermediate, and resistant seems warranted, although the boundaries require additional study. The genotypic assay proved a reliable and rapid method for predicting aminoglycoside and fluoroquinolone resistance." @default.
• W2103876802 created "2016-06-24" @default.
• W2103876802 creator A5010141975 @default.
• W2103876802 creator A5011722549 @default.
• W2103876802 creator A5025754154 @default.
• W2103876802 creator A5031642594 @default.
• W2103876802 creator A5035886916 @default.
• W2103876802 creator A5080158752 @default.
• W2103876802 creator A5086686331 @default.
• W2103876802 date "2010-08-01" @default.
• W2103876802 modified "2023-10-17" @default.
• W2103876802 title "Comparative Study on Genotypic and Phenotypic Second-Line Drug Resistance Testing of <i>Mycobacterium tuberculosis</i> Complex Isolates" @default.
• W2103876802 cites W1966126698 @default.
• W2103876802 cites W1993702425 @default.
• W2103876802 cites W1998579972 @default.
• W2103876802 cites W2016620483 @default.
• W2103876802 cites W2046417607 @default.
• W2103876802 cites W2096624362 @default.
• W2103876802 cites W2098407985 @default.
• W2103876802 cites W2116175177 @default.
• W2103876802 cites W2127897988 @default.
• W2103876802 cites W2137088409 @default.
• W2103876802 cites W2137481485 @default.
• W2103876802 cites W2146832771 @default.
• W2103876802 cites W2168859775 @default.
• W2103876802 cites W2170393472 @default.
• W2103876802 cites W4229660860 @default.
• W2103876802 doi "https://doi.org/10.1128/jcm.00652-10" @default.
• W2103876802 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2916561" @default.
• W2103876802 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20554815" @default.
• W2103876802 hasPublicationYear "2010" @default.
• W2103876802 type Work @default.
• W2103876802 sameAs 2103876802 @default.
• W2103876802 citedByCount "55" @default.
• W2103876802 countsByYear W21038768022012 @default.
• W2103876802 countsByYear W21038768022013 @default.
• W2103876802 countsByYear W21038768022014 @default.
• W2103876802 countsByYear W21038768022015 @default.
• W2103876802 countsByYear W21038768022016 @default.
• W2103876802 countsByYear W21038768022017 @default.
• W2103876802 countsByYear W21038768022018 @default.
• W2103876802 countsByYear W21038768022019 @default.
• W2103876802 countsByYear W21038768022020 @default.
• W2103876802 countsByYear W21038768022022 @default.
• W2103876802 countsByYear W21038768022023 @default.
• W2103876802 crossrefType "journal-article" @default.
• W2103876802 hasAuthorship W2103876802A5010141975 @default.
• W2103876802 hasAuthorship W2103876802A5011722549 @default.
• W2103876802 hasAuthorship W2103876802A5025754154 @default.
• W2103876802 hasAuthorship W2103876802A5031642594 @default.
• W2103876802 hasAuthorship W2103876802A5035886916 @default.
• W2103876802 hasAuthorship W2103876802A5080158752 @default.
• W2103876802 hasAuthorship W2103876802A5086686331 @default.
• W2103876802 hasBestOaLocation W21038768022 @default.
• W2103876802 hasConcept C142724271 @default.
• W2103876802 hasConcept C176947019 @default.
• W2103876802 hasConcept C203014093 @default.
• W2103876802 hasConcept C2776228421 @default.
• W2103876802 hasConcept C2776297342 @default.
• W2103876802 hasConcept C2776962512 @default.
• W2103876802 hasConcept C2777427914 @default.
• W2103876802 hasConcept C2777975735 @default.
• W2103876802 hasConcept C2778607973 @default.
• W2103876802 hasConcept C2778836808 @default.
• W2103876802 hasConcept C2778980435 @default.
• W2103876802 hasConcept C2779489039 @default.
• W2103876802 hasConcept C2780493024 @default.
• W2103876802 hasConcept C2780695269 @default.
• W2103876802 hasConcept C2780867798 @default.
• W2103876802 hasConcept C2781019175 @default.
• W2103876802 hasConcept C2781069245 @default.
• W2103876802 hasConcept C2781414143 @default.
• W2103876802 hasConcept C3019249092 @default.
• W2103876802 hasConcept C501593827 @default.
• W2103876802 hasConcept C523546767 @default.
• W2103876802 hasConcept C54355233 @default.
• W2103876802 hasConcept C71924100 @default.
• W2103876802 hasConcept C81396022 @default.
• W2103876802 hasConcept C86803240 @default.
• W2103876802 hasConcept C89423630 @default.
• W2103876802 hasConceptScore W2103876802C142724271 @default.
• W2103876802 hasConceptScore W2103876802C176947019 @default.
• W2103876802 hasConceptScore W2103876802C203014093 @default.
• W2103876802 hasConceptScore W2103876802C2776228421 @default.
• W2103876802 hasConceptScore W2103876802C2776297342 @default.
• W2103876802 hasConceptScore W2103876802C2776962512 @default.
• W2103876802 hasConceptScore W2103876802C2777427914 @default.
• W2103876802 hasConceptScore W2103876802C2777975735 @default.
• W2103876802 hasConceptScore W2103876802C2778607973 @default.
• W2103876802 hasConceptScore W2103876802C2778836808 @default.
• W2103876802 hasConceptScore W2103876802C2778980435 @default.
• W2103876802 hasConceptScore W2103876802C2779489039 @default.
• W2103876802 hasConceptScore W2103876802C2780493024 @default.
• W2103876802 hasConceptScore W2103876802C2780695269 @default.
• W2103876802 hasConceptScore W2103876802C2780867798 @default.
• W2103876802 hasConceptScore W2103876802C2781019175 @default.
• W2103876802 hasConceptScore W2103876802C2781069245 @default.
• W2103876802 hasConceptScore W2103876802C2781414143 @default.

• next